GABAB receptors within the central nucleus of amygdala may involve in the morphine-induced incentive tolerance in female rats

Document Type : Original Article


1 Department of Basic Sciences, Farhangian University, Tehran, Iran

2 Departments of Biology, Faculty of Science, Malayer University, Malayer, Iran


Objective(s): Central nucleus of amygdala (CeA) is the most important region for morphine-induced reward, and GABAergic system plays an important role on morphine reinforcement. The influence of CeA administration of GABAB receptor agonist and antagonist on the expression and acquisition of morphine-induced incentive tolerance using conditioned place preference (CPP) paradigm was investigated in the present study. Our purpose was to evaluate the role of CeA GABAB receptors in morphine tolerance.
Materials and Methods: Seven days after surgery and cannulation, the experiments were begun. Subcutaneous (SC) injections of morphine induced CPP. Administration of one daily dose of morphine (12.5 mg/kg) for 3 days in order to develop tolerance to the drug reduced the conditioning induced by morphine (7.5 mg/kg, SC). GABAB receptor agonist, baclofen (1.5, 6 and 12 µg/rat) or GABAB receptor antagonist, CGP35348 (1.5, 6 and 12 µg/rat) were injected into the CeA 5 min before the experiments in the test day (expression of tolerance) or 5 min before each injection of morphine (12.5 mg/kg) (acquisition of tolerance).
Results: It was shown that injections of baclofen (1.5 and 12 µg/rat) reduced acquisition, whereas the dose of 6 µg/rat of the drug exacerbated the acquisition of morphine tolerance. Baclofen at all doses significantly increased the expression of tolerance to morphine. Administration of CGP35348 (1.5, 6 and 12 µg/rat) reduced the acquisition and expression of morphine tolerance.
Conclusion: These results confirmed the importance of GABAB receptors with in the CeA in morphine tolerance in female rats.


1. Morris BJ, Herz A. Control of opiate receptor numberin vivo: Simultaneous κ-receptor down-regulation and μ-receptor up-regulation following chronic agonist/antagonist treatment. Neuroscience 1989; 29:433-442.
2. Parvardeh S, Moghimi M, Eslami P, Masoudi A. α-Terpineol attenuates morphine-induced physical dependence and tolerance in mice: role of nitric oxide. Iran J Basic Med Sci 2016;19:201-208.
3. Khatibi A, Haghparast A, Shams J, Dianati E, Komaki A, Kamalinejad M. Effects of the fruit essential oil of Cuminum cyminum L. on the acquisition and expression of morphine-induced conditioned place preference in mice. Neurosci lett 2008; 448:94-98. 
4. Sahraei H, Falahi M, Zarrindast MR, Sabetkasaei M, Ghoshooni H, Khalili M. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur J Pharmacol 2004; 503:81-87.
5. Kiraly K, Caputi FF, Hanuska A, Kató  Eb, Balogh M, Köles Ls, et al. A new potent analgesic agent with reduced liability to produce morphine tolerance. Brain Res Bull 2015; 117:32-38.
6. Chao J, Nestler EJ. Molecular neurobiology of drug addiction. Annu Rev Med 2004; 55:113-132.
7. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251:85-87.
8. Steffensen SC, Lee RS, Stobbs SH, Henriksen SJ. Responses of ventral tegmental area GABA neurons to brain stimulation reward. Brain Res 2001; 906:190-197.
9. Padgett CL, Lalive AL, Tan KR, Terunuma M, Munoz MB, Pangalos MN, et al. Methamphetamine-evoked depression of GABA B receptor signaling in GABA neurons of the VTA. Neuron 2012; 73:978-989.
10. Sahraei H, Etemadi L, Rostami P, Pourmotabbed A, Zarrindast M-R, Shams J, et al. GABA B receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacol Biochem Behav 2009;91:409-416.
11. Ferbinteanu J, McDonald RJ. Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus 2001; 11:187-200.
12. De Vries TJ, Shippenberg TS. Neural systems underlying opiate addiction.  J Neurosci 2002; 22:3321-3325.
13. Phillips TJ, Reed C. Targeting GABAB receptors for anti-abuse drug discovery. Exp Opin Drug Discov 2014;9:1307-1317.
14. Franklin TR, Harper D, Kampman K, Kildea-McCrea S, Jens W, Lynch KG, et al. The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend 2009;103:30-36.
15. Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res 2003;987:122-125.
16. Xi Z-X, Stein EA. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 1999; 290:1369-1374.
17. Chalabi-Yani D, Sahraei H, Meftahi GH, Hosseini SB, Sadeghi-Gharajehdaghi S, Beig HA, et al. Effect of transient inactivation of ventral tegmental area on the expression and acquisition of nicotine-induced conditioned place preference in rats. Iran Biomed J 2015;19:214.
18.  Bijani S, Sadeghi-Gharachehdaghi S, Zardooz H, Ghoshooni H, Eidi A, Shams J, et al. Influence of nitric oxide in the central amygdala on the acquisition and expression of morphine-induced place preference in morphine sensitized rats. Basic Clin Neurosci 2011; 2:36-46.
19. Chen X, Marrero HG, Murphy R, Lin Y-J, Freedman JE. Altered gating of opiate receptor-modulated K+ channels on amygdala neurons of morphine-dependent rats. Proc Nat Acad Sci 2000;97:14692-14696.
20. Arout CA, Caldwell M, Rossi G, Kest B. Spinal and supraspinal N-methyl-d-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia. Physiol Behav 2015;147:364-372.
21. Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP. Sex and estrogen influence drug abuse. Trends Pharmacol Sci 2004;25:273-279.
22. Cicero TJ, Ennis T, Ogden J, Meyer ER. Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav 2000;65:91-96.
23. Rafieirad M, Sahraei H, Haeri RSA, Sepehri H, Alavian DS, Ghoshouni H, et al. The modulatory role of gaba-b receptors of the shell part of nucleus accumbens in the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. physiology and pharmacology. 2007; 11:182-191.
24. Karami M, Zarrindast MR, Sepehri H, Sahraei H. Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference. Eur J Pharmacol 2002; 449:113-119.
25. Zarrindast MR, Faraji N, Rostami P, Sahraei H, Ghoshouni H. Cross-tolerance between morphine-and nicotine-induced conditioned place preference in mice. Pharmacol Biochem Behav 2003;74:363-369.
26. Zarrindast MR, Rezayof A. Morphine-induced place preference: interactions with neurotransmitter systems. Iran J Pharm Res 2010;3-15.
27. Pockros-Burgess LA, Pentkowski NS, Der-Ghazarian T, Neisewander JL. Effects of the 5-HT2C receptor agonist
CP809101 in the amygdala on reinstatement of cocaine-seeking behavior and anxiety-like behavior. Int J Neuropsychopharmacol 2014; 17:1751-1762.
28. Paxinos G, Watson C. The rat brain in stereotaxic atlas. London: Academic; 1986.
29. Sahraei H, Ghazzaghi H, Zarrindast M-R, Ghoshooni H, Sepehri H, Haeri-Rohan A. The role of alpha-adrenoceptor mechanism (s) in morphine-induced conditioned place preference in female mice. Pharmacol Biochem Behav 2004;78:135-141.
30. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988; 242:715-723.
31. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13:177-184.
32. Loh HH, Liu H-C, Cavalli A, Yang W, Chen YF, Wei LN. μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Mol Brain Res 1998;54:321-326.
33. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999; 22:521-527.
34. Karami M, Zarrindast MR. Place aversion by morphine in offspring born of female morphine administered wistar rats. Iran J Pharm Res 2011; 10:577.
35. Bexis S, Ong J, White J. Attenuation of morphine withdrawal signs by the GABA B receptor agonist baclofen. Life Sci 2001; 70:395-401.
36. Macey DJ, Froestl W, Koob GF, Markou A. Both GABA B receptor agonist and antagonists decreased brain stimulation reward in the rat. Neuropharmacology 2001; 40:676-685.
37. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001;2:695-703.
38. Bernard C, Cossart R, Hirsch JC, Esclapez M, Ben‐Ari Y. What is GABAergic inhibition? How is it modified in
epilepsy? Epilepsia 2000;41:S90-S95.
39. Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABAB receptors. Physiol Rev 2004; 84:835-867.
40. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, et al. International union of pharmacology. XXXIII. Mammalian γ-aminobutyriC acidB receptors: structure and function. Pharmacol Rev 2002; 54:247-264.
41. Leite-Morris KA, Fukudome EY, Kaplan GB. Opiate-induced motor stimulation is regulated by γ-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neurosci Lett 2002; 317:119-122.
42. Leite-Morris KA, Fukudome EY, Shoeb MH, Kaplan GB. GABAB receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. J Pharmacol Exp Ther 2004; 308:667-678.
43. Tsuji M, Nakagawa Y, Ishibashi Y, Yoshii T, Takashima T, Shimada M, et al. Activation of ventral tegmental GABA B receptors inhibits morphine-induced place preference in rats. Eur J Pharmacol 1996; 313:169-173.
44. Shoaib M, Swanner LS, Beyer CE, Goldberg SR, Schindler CW. The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol 1998;  9:195-206.
45. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001;81:299-343.
46. Veinante P, Yalcin I, Barrot M. The amygdala between sensation and affect: a role in pain. J Mol Psychiatry 2013; 1:9.
47. Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 2015; 11:165.